Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary FibrosisJose D. Herazo‐Maya, Naftali Kaminski, Imre Noth et al.|Science Translational Medicine|2013Cited by 350
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort studyJose D. Herazo‐Maya, Naftali Kaminski, Melinda Klesen et al.|The Lancet Respiratory Medicine|2017Cited by 191
Precision medicine advances in idiopathic pulmonary fibrosisΤheodoros Karampitsakos, Jose D. Herazo‐Maya, Brenda Juan-Guardela et al.|EBioMedicine|2023Cited by 150
Integrative phenotyping framework (iPF): integrative clustering of multiple omics data identifies novel lung disease subphenotypesSunghwan Kim, Naftali Kaminski, Jose D. Herazo‐Maya et al.|BMC Genomics|2015Cited by 139
Matrix Metalloproteinase-19 Promotes Metastatic Behavior <i>In Vitro</i> and is Associated with Increased Mortality in Non–Small Cell Lung CancerGuoying Yu, Daniel J. Kass, Jose D. Herazo‐Maya et al.|American Journal of Respiratory and Critical Care Medicine|2014Cited by 95